Clinical Trial Update: Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2 [Phase 3]

View source ↗

Summary

A Phase III clinical trial is investigating induction and consolidation chemotherapy with venetoclax for newly diagnosed acute myeloid leukemia and myelodysplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome with Excess Blasts-2

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: University of Ulm | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: RECRUITING